Patients with non-ischemic cardiomyopathy are largely regarded to derive superior response to cardiac resynchronization therapy (CRT)compared to ischemic patients. Patients with non-ischemic cardiomyopathy (NICM), however, are heterogeneous with multiple different… Click to show full abstract
Patients with non-ischemic cardiomyopathy are largely regarded to derive superior response to cardiac resynchronization therapy (CRT)compared to ischemic patients. Patients with non-ischemic cardiomyopathy (NICM), however, are heterogeneous with multiple different myocardial substrates. We sought to
               
Click one of the above tabs to view related content.